Adaptimmune Therapeutics
ADAP
#9428
Rank
โ‚น4.92 B
Marketcap
โ‚น19.16
Share price
-13.19%
Change (1 day)
-83.08%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -โ‚น43.78

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น45.97. In 2022 the company made an earnings per share (EPS) of -โ‚น87.85 a decrease over its 2021 EPS that were of -โ‚น87.85.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น43.78-50.16%
2022-โ‚น87.85-0%
2021-โ‚น87.856.25%
2020-โ‚น82.69-27.27%
2019-โ‚น113.6929.41%
2018-โ‚น87.8520.09%
2017-โ‚น73.16-16.73%
2016-โ‚น87.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น619.28 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น80.96 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น339.36 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น24.40-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA